why choose us

First received: July 1, 2022

Clinical Trial: PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients

Study Status: Completed

Recruit Status: Completed

Condition: Prostate Cancer

Study Type: Observational [Patient Registry]


Official Title: A Multi-center Prospective Observational Study of Community Urology Practices Applying Germline Genetic Testing for Prostate Cancer Patients (PROCLAIM)

Brief Summary: This registry is for men who have prostate cancer and have had multigene panel hereditary testing. The registry will gather data on genetic testing results and how that information may change physician treatment or follow up recommendations. It will also gather data on the patient's experience with genetic testing, through a post-test survey to be completed 60-90days after results have been received and discussed with their provider.

Read more